Showing 1,081 - 1,100 results of 8,337 for search '"Diabetes"', query time: 0.10s Refine Results
  1. 1081
  2. 1082
  3. 1083
  4. 1084
  5. 1085

    Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes by Noelle N. Gronroos, Caroline Swift, Monica S. Frazer, Andrew Sargent, Michael Leszko, Erin Buysman, Sara Alvarez, Tyler J. Dunn, Josh Noone

    Published 2024-11-01
    “…**Background:** Medical management of patients with type 2 diabetes mellitus (T2DM) is complex because of the chronic nature of the disease and its associated comorbidities. …”
    Get full text
    Article
  6. 1086
  7. 1087
  8. 1088
  9. 1089
  10. 1090
  11. 1091
  12. 1092
  13. 1093
  14. 1094
  15. 1095
  16. 1096
  17. 1097
  18. 1098

    The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease by Hongtu Hu, Wei Liang, Zongwei Zhang, Zikang Liu, Fan Chu, Yan Bao, Jialu Ran, Guohua Ding

    Published 2022-01-01
    “…In a cross-sectional analysis, patients with diabetes and higher PFT presented with higher albuminuria. …”
    Get full text
    Article
  19. 1099

    Abdominal Adiposity Distribution in Diabetic/Prediabetic and Nondiabetic Populations: A Meta-Analysis by Jane J. Lee, S. Natasha Beretvas, Jeanne H. Freeland-Graves

    Published 2014-01-01
    “…Evidence suggests that visceral adiposity has greater implications for diabetes than other fat depots. The purpose of this study is to explore the disparities in the distribution of abdominal adiposity in diabetic/prediabetic and nondiabetic populations and to identify moderators that influence the pattern of central obesity via a meta-analysis technique. …”
    Get full text
    Article
  20. 1100

    Effects of Short Term Exposure of Atrazine on the Liver and Kidney of Normal and Diabetic Rats by Dinesh Babu Jestadi, Alugoju Phaniendra, Undru Babji, Thupakula Srinu, Bhavatharini Shanmuganathan, Latha Periyasamy

    Published 2014-01-01
    “…The present study evaluates the effects of short term (15 days) exposure of low dose (300 μg kg−1) of atrazine (2-chloro-4-ethylamino-6-isopropylamino-1,3,5-triazine) on antioxidant status and markers of liver and kidney damage in normal (nondiabetic) and diabetic male Wistar rats. Rats were divided into four groups: Group I as normal control, Group II as atrazine treated, Group III as diabetic control, and Group IV as atrazine treated diabetic rats. …”
    Get full text
    Article